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ABSTRACT 
Xanthene dyes are common fluorophores which have been widely used as 
molecular probes. The xanthene fluorophores can be used as highly selective optical 
sensors to detect disease biomarkers. A new fluorogenic dye containing an ,-
unsaturated aldehyde moiety exhibits selective fluorescent signal enhancement in the 
presence of cysteine or peptides containing N-terminal cysteine residues. The mechanism 
is based on synergistic covalent and supramolecular interactions.  
A unique rhodamine boronic acid indicator is used in an optimized data collection 
protocol for wavelength- and time-dependent selectivity of various saccharides and 
nucleosides. One indicator is thereby capable of selectively distinguishing structurally 
related analytes in mixtures.  Moreover, the rhodamine-based boronic acid responds 
linearly to increasing riboside concentrations in urine samples, potentially enabling the 
screening for inborn purine metabolism disorders. 
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CHAPTER 1.  INTRODUCTION  
The development of simple optical indicators to detect small molecule disease 
biomarkers is of great interest. Current clinical chemistry techniques can benefit from 
user friendly and simple techniques for the direct analysis of analytes in complex 
biological matrices. Research described herein focuses on the sensing of biological thiols, 
peptides, and specific ribose-containing molecules via xanthene-based organic dye 
indicators. 
1.1 Fluorescent Indicators 
Organic and bioorganic molecules as analytes pose unique challenges for the 
design of selective indicators. They include a wide range of structures, dynamics and 
interacting moieties. The majority of the indicators reported to date were designed for 
detecting metal cations and inorganic or highly polar anionic molecules. These latter 
efforts were inspired, for instance, by Tsien’s cation-binding fluorophores.1 In fact, 
fluorescent chemical indicators for sodium, potassium and calcium currently are the 
platforms for a portable blood gas analyzer for point-of-care use in hospitals and 
ambulances.2  
1.2 Indicators for the Specific Detection of Cysteine and N-Terminal Cysteine 
Peptide Residues  
 
 Biological thiols help modulate many redox processes in nature. Altered levels of 
thiols signify various disease states including cancer and AIDS.3 Thus, the creation of 
effective probes for biological thiols is an ongoing area of study. Many fluorescent 
reagents have been reported by several research groups worldwide. The chemical 
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mechanisms for signal transduction are diverse. They include cleavage by thiol attack, 
ring opening reactions, Michael additions, or cyclizations with aldehydes.  
Aldehyde-functionalized fluorophores and chromophores can be used for the 
simple and highly selective detection of cysteine (Cys) and/or homocysteine (Hcy) upon 
thiazinane or thiazolidine formation. Additionally, Cys vs. Hcy selectivity is also 
achieved via the use of -unsaturated aldehydes under mild conditions involving 
related mechanisms.4, 5  
 
Figure 1.1 Chapter 2 describes the selective detection of Cys via an -unsaturated 
aldehyde-appended fluorescein derivative. 
 
1.3 Multidimensional Multiple Analyte Detection via a Single Indicator 
Generally, fluorescence detection is analyzed by the fluorescence response from 
the interaction between the analyte and indicator or receptor. However, fluorophores used 
in complex natural media can form unexpected multi-component complexes that may 
hinder selective detection and challenge the determination of optimal spectroscopic 
properties. An improved data collection protocol, such as multidimensional data analysis 
which measures fluorescence of sample at several different excitation wavelengths for 
several emission wavelengths, can solve the problems from the presence of a variety of 
indicator-bound species. Also, this wavelength-tunable detection enables multiple analyte 
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detection via a single optical indicator based on the different dynamics of each reaction 
complex, simultaneously with saving time and materials. 
 
Figure 1.2 Chapter 3 describes multidimensional data analysis and its application to 
multiple analyte detection via a single indicator. 
 
1.4 Direct Detection of ADSL Deficiency in Human Urine 
Although rare (approximately 1 in 200,000 births), adenolosuccinate lyase 
(ADSL) deficiency is a serious inborn error of purine metabolism.  It is one of the autism 
spectrum disorders. ADSL deficiency is associated with mental retardation, congenital 
blindness, autism and seizure.6 It can be diagnosed via massive levels (mM) of succinyl-
5-amino-4-imidazolecarboxamide riboside (SAICA-riboside) and succinyladenosine (S-
Ado) in urine of these patients.  
Existing screening tests for ADSL deficiency, for example the Bratton-Marshall 
test, are non-specific and exhibit high rates of false positives. TLC screening with Pauly 
reagent requires fresh reagent preparation prior to use, and analyte separations. 
Developing stable and selective reagents for SAICAr and S-Ado directly in urine without 
separations is necessary for convenient screening for this devastating disease of infants. 
Such tests would also guide the development of other nucleoside and nucleotide 
indicators for the detection of various cancers. 
 4
+
HN
B(OH)2
O
CO2H
N
(HO)2B
 
Figure 1.3 Chapter 4 describes the selective detection of AICAr directly in human urine 
without sample processing, towards the development of a practical assay for ADSL 
deficiency. 
 
1.5 Research Goal 
A goal of the work described herein is developing fluorogenic dyes for detecting 
specific amino acids and saccharides in challenging natural media.  This includes (i) 
understanding synergistic covalent and non-covalent interactions between the fluorophore 
and bound analyte, (ii) site-specific peptide and protein residue detection, (iii) the 
advantage of time and wavelength dependent detection for multiple analyte sensing via 
one indicator, (iv) simple and direct analyses of ADSL deficiency biomarkers in urine, 
(v) monitoring the concentration of analytes of interests in real clinical samples via 
quantitative means. 
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CHAPTER 2. SELECTIVE FLUORESCENCE DETECTION OF CYSTEINE 
AND N-TERMINAL CYSTEINE PEPTIDE RESIDUES 
 
An ,-unsaturated aldehyde-functionalized fluorescein produces a significant 
fluorescent signal enhancement in solutions containing cysteine and peptides containing 
N-terminal cysteine residues. A unique combination of covalent and supramolecular 
interactions between fluorophore and analyte promotes the selectivity among the 
aminothiols.  
2.1 Background 
2.1.1 Biological Thiols 
Biological thiols play key roles in the regulation of numerous biochemical redox 
processes. A deficiency or excess of specific biological thiols is related to various 
syndromes and the alteration in these thiols serves as evidence of disease states, such as 
cancer and AIDS.3 
 
 
Figure 2.1 Some common biological thiols. 
 
Cysteine (Cys) is a biosynthesized nonessential amino which is an important 
catalytic center of many thiol-containing enzymes, and involved in human neuronal cell-
lines.7 An excess of Cys in vitro, in the presence of bicarbonate ions, has been reported to 
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cause neuronal death by an excitotoxic mechanism in a calcium dependent manner.8 
Elevation of cysteine concentrations in particular neurons may contribute to 
neurodegenerative brain disorders, such as Parkinson’s, Alzheimer’s, or motor neuron 
disease.9 On the other hand, abnormally low levels of plasma cystine and cysteine, and 
intracellular glutathione were found in patients with HIV infection.10 
2.1.2 General Thiol Detection Methods 
The investigation of fluorescent probes for thiol detection is an active area of 
study.3, 11 Derivatives of fluorescent reagents have been reported by many groups and the 
mechanisms for fluorescence modulation are diverse. They include cleavage of electron 
withdrawing groups by thiols,12-15 Michael additions,16-23 or cyclizations with 
aldehydes.24-30 
Typically the cleavage type turn-on probes are non- or weakly fluorescent when 
they contain strong electron-withdrawing groups such as 2,4-dinitrobenzenesulfonyl 
(DNBS).12-14 However, they show intensity enhancement upon cleavage of the electron-
withdrawing group in the presence of thiols. The DNBS functionalized fluorescein 
derivative displayed high intensity and short reaction times, but was sensitive to 
hydrolysis in aqueous solutions.12 Abe et al. used a DNBS rhodamine 110 (Fig. 2.2, left 
bottom), that was used for the monitoring of thiols in living human cells.13 
Sensors based on Michael addition are also being developed for thiol detection. 
Various maleimide-base probes have been reported,18-20 but often the reaction conditions 
are limited to pH < 7 to avoid hydrolysis of the maleimide.19 Keillor et al. synthesized a 
series of dimaleimide containing fluorophores (Fig. 2.3, top) that react with 2 equiv 
monothiols or 1 equiv of dithiols.20 These fluorogens efficiently labeled a recombinant -
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helical protein in vitro, which demonstrated potential utility for the labeling of specific 
proteins. 
  
 
 
Figure 2.2 DNBS cleavage type fluorescent probes.13, 14 
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Figure 2.3 Some dimaleimide derivative probes (top)20, and a ketocoumarin derivative 
(bottom)21.  
 
Lin et al. designed an -unsaturated fluorescent probe (Fig. 2.3, bottom) for the 
conjugate addition of thiols.21 The coumarin based probe is highly sensitive (211-fold 
enhancements for Cys) for thiols with a low limit of detection (LOD of 9.25 x 10-7 M) at 
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physiological pH, but the relatively small quantum yield of the fluorophore in water 
limits its use in bioimaging. 
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Figure 2.4 Squaraine derivative probes.22, 23 
Martínez-Máñez et al. reported simple, water-soluble, easy synthesized squaraine 
derivative thiol probes (Fig. 2.4, top).22 The squaraine probes showed an intense band at 
relatively long wavelength (ca. 640 nm). Selective fluorescence quenching was observed 
in the presence of cysteine among various amino acids. However, squaraines are sensitive 
to the pH of the surrounding media. An improved extended squaraine dye (Fig. 2.4, 
bottom) exhibits absorption shifts and emission changes in the near infrared region in the 
presence of amino thiols in human blood plasma.23  
 2.1.3 Thiol Detection Probes based on Cyclizations with Aldehydes 
 Aldehyde-functionalized fluorophores and chromophores have been used for 
highly selective detection of cysteine and/or homocysteine over all other sulfhydryls due 
to characteristic thiazolidine or thiazinane formation, respectively (Table 2.1). 
 In 2004, the Strongin group reported a dialdehyde functionalized fluorescein dye 
for colorimetric and fluorimetric detection of Cys and Hcy.25 The probe showed visible 
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color changes with added Cys and Hcy (25 nm red shift), and fluorescence quenching in a 
pH 9.5 buffer solution. These results stimulated the further development of fluorogenic 
aldehydes for the detection of Cys and Hcy. 
 Tanaka and Barbas, III et al. introduced a fluorescence enhancement method for 
the detection of Cys at neutral pH.26 The probe reacted with Cys and resulted in a 
fluorescence increase at 380 nm, and allowed one to determine the concentration of Cys 
in a range of 100 m
 A ratiometric phenanthroline-based probe was designed by Lin et al.27 The probe 
in the presence of Cys/Hcy showed a large emission blue shift (125 nm) via an 
intramolecular charge transfer (ICT). While the phenanthroimidazole moiety works as 
both a fluorophore and electron donor in the ICT system, the aldehyde group functions as 
an electron acceptor and reacts with Cys and Hcy, respectively. Upon addition of 
Cys/Hcy, the probe displayed an intensity decrease at 519 nm with the growth of a locally 
excited band at 394 nm. 
  Two coumarin-based fluorescent probes exhibiting photoinduced electron 
transfer (PET) effects were reported for the detection of amino thiols.28, 29 A 
salicylaldehyde functionalized turn-on probe showed a more than 100-fold fluorescence 
enhancement in the presence of homocysteine.29 This fluorescence intensity enhancement 
was also monitored in human blood plasma with excess GSH. 
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Structure Properties Ref.
 
a) Targeting analytes: 
    Cysteine, Homocysteine 
b) Solution: carbonate buffer pH 9.5 
c) Em 510 nm, Abs 480 nm 
 
25 
N
H
O
O
H  
A fluorescent increase observed 
a) Cysteine 
b) CH3CN: 2-PrOH: buffer pH 7.0 
c) Em 380 nm 
26 
 
A ratiometric fluorescent probe 
a) Cysteine, Homocysteine 
b) DMF: HEPES buffer pH 7.4 
c) Em 519 nm, Abs 376nm 
27 
 
PET quenching 
a) Cysteine, Homocysteine 
b) Ethanol 
c) Em 488 nm 
28 
OO OH
OH
 
Fluorescent “turn-on” probe 
a) Homocysteine over Cysteine 
b) HEPES buffer pH 7.4 
c) Em 450 nm 
29 
N
O
O
O
H
O
H
 
25 nm red shift in emission band 
a) Cysteine 
b) EtOH: HEPES buffer pH 7.2 
c) Em 480 nm, Abs 375 nm 
30 
 
Table 2.1 Selected aldehyde functionalized fluorescent probes based on thiol cyclization. 
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Qian et al. designed a 1,8-naphthylamide-based fluorescent probe for the 
determination of cysteine.30 The probe showed an increase in fluorescence intensity with 
a 25 nm red shift in emission (from 455 to 480 nm) along with a fluorescence color 
change from blue to cyan. The probe was proposed as potential bioimaging indicator for 
cellular cysteine, and showed an intense intracellular fluorescence after 2 h incubation in 
cell culture. 
2.1.4 -unsaturated Aldehydes for Cysteine Detection 
In 1976 Scholz and co-works successfully investigated the reaction of cysteine 
with -unsaturated aldehydes based on the knowledge of well known reaction between 
thiols and saturated aldehydes or ketones.31 A decade later, the concept was turned into 
first colorimetric assay that cysteine reacts with cinnamaldehyde (Fig. 2.5) at 600 C in 
methanol, in presence of catalytic amounts of sulfuric acid.32 The absorption max of 
reaction product was observed at 587 nm. This method has been widely used as the 
detection method for free cysteine in solutions and TLC tests. 
 
Figure 2.5 p-dimethylaminocinnamaldehyde. 
Moreover, selectivity for Cys using -unsaturated aldehydes has been directly 
achieved at room temperature via visible detection.5 Non-fluorescent p-
dimethylaminocinnamaldehyde (Fig. 2.5) exhibited high selectivity for cysteine in the 
presence of homocysteine with color bleaching (from yellow to colorless). This result led 
to the application of unsaturated aldehydes appended to fluorescein, a common 
fluorophore. 
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Unlike previous work in which the response toward thiols resulted in fluorescence 
quenching,25 a new fluorogenic fluorescein derivative 2.1 exhibits a combination of 
covalent and non-covalent interactions between the fluorophore and bound analyte. This 
generates a turn-on fluorescence response. These unique interactions result in heightened 
selectivity, emission, site-specific peptide and protein residue detection and amplified 
selectivity as a function of bound analyte complexity.  
2.2 Synthesis of an -unsaturated Fluorescein Monoaldehyde 
 Compound 2.1 is synthesized via the Reimer-Tiemann formylation of fluorescein 
to afford the intermediate aldehyde followed by heating with triphenyl-
phosphoranylidene acetaldehyde in CHCl3.  
COO
OHO O
2.1
O
COO
OHO O
NaOH(aq)
CHCl3/MeOH
COO
OHO O
O
15-crown-5
Ph3P=CH-CHO
CHCl3
 
 
Scheme 2.1 Synthesis of Mono--unsaturated Fluorescein Aldehyde 2.1. 
 
2.3 Results and Discussion 
2.3.1 Conjugate Addition and Thiazolidine Formation of Cysteine 
The reaction mechanism proposed is nucleophilic attack by the Cys sulfhydril on 
the -carbon of 2.1 followed by thiazolidine formation with a second Cys molecule via 
the aldehyde carbonyl (Scheme 2.2). The disappearance of the corresponding aldehyde 
resonances at 9.29 ppm (d, J= 8.4 Hz, 1H), and olefin resonances at 7.97 ppm (d, J= 15.8 
Hz, 1H) and 7.24 ppm (dd, J= 8.4, 15.8 Hz, 1H) of 2.1, with the simultaneous appearance 
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of thiazolidine resonances in the 1H NMR centered at ca. 6.72 ppm confirms 2 equiv Cys 
reacted with 2.1 (Fig. 2.6). This assignment is confirmed with ESI-TOF HRMS evidence 
(Fig. A4 in Appendix), showing a prominent peak at m/z 609.3 (the calculated exact mass 
of Cys- 2.1 complex is 609.0992) representing the reaction as 2 equiv Cys with 2.1. The 
signal of 1:1 adduct at m/z 488.3 is only 10 % of that of the bis-adduct. 
 
Scheme 2.2 The reaction of 2.1 with Cys (excess) in 0.1 M phosphate buffer pH 7.4 at rt. 
 
Figure 2.6 1H-NMR spectra vs. times in 0.1M pH 7.4 phosphate buffer/D2O 9:1; (A) 
compound 2.1 only; (B) 2.1 and Cys after 5 min; (C) 2.1 and Cys after 1 h; (D) 2.1 and 
Cys after 4 h. 
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2.3.2 The Absorption and Fluorescence Properties of Mono--
unsaturated Fluorescein Aldehyde 
 
The absorption properties are similar to those of typical fluoresceins.33 The 
fluorescein concentration is adjusted so that it has an equal absorbance to that of 2.1 at 
463nm (abs=0.042). It is clear that epsilon values are similar with 2.1 (501=46981 cm-1 
M-1 in 0.1 M phosphate buffer pH 7.4, Fig. 2.7) being slightly red shifted as compared to 
fluorescein (abs max ~502nm). The absorption spectra of 2.1 as a function of pH reveal 
an isosbestic point at 463 nm (Fig. 2.8). 
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
50000
250 300 350 400 450 500 550
wavelength (nm)
M
ol
ar
 a
bs
or
pt
iv
ity
 (1
/c
m
 M
)
  
Figure 2.7 Absorption of 2.1 (501=46981 cm-1 M-1 in 0.1 M phosphate buffer pH 7.4).  
 
Figure 2.8 Absorption of 2.1 as a function of pH (2 M 2.1 in 0.1 M phosphate buffer 
pH 5.5 - 9.0). Arrows indicate direction of change with increasing pH. * marks the 
location of well defined isosbestic points at 340 nm, 396 nm, 426 nm, 463 nm. 
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In the absence of analyte, the emission of 2.1 is suppressed as compared to 
fluorescein as a result of the extended conjugation and electron withdrawing aldehyde, 
however, the spectral shape is similar (slight red shift of <5 nm). Based on the λmax 
intensities, fluorescein is 23.09 times brighter than 2.1 (based on integrated intensities 
fluourescein is 16.35 times brighter). The addition of a large excess of Cys (10 mM) to a 
2 M solution of 2.1 resulted in a negligible change in absorbance at the 463 nm 
excitation wavelength (with a relatively small 20% increase in absorbance and slight 3 
nm blue shift at the peak max) but restores much the fluorescence (Fig. 2.9). Therefore, 
the emission intensities are directly proportional to the relative quantum yields of the 
system. The quantum yield of 2.1 is calculated to be 0.054 and that of Cys with 2.1 
reaction product is calculated to be 0.289, as compared to fluorescein (fluorescein pH 7.4 = 
0.876) 33 under the same conditions (ex = 463 nm, 0.1 M phosphate buffer pH 7.4). 
We optimized the fluorogenic response of compound 2.1 to Cys through 
investigation of the absorption and excitation properties of 2.1 and of its reaction product 
with Cys as it formed over time. In the absence of Cys, the excitation spectrum of 2.1 is 
blue shifted as compared to the corresponding absorption spectrum (Inset Fig. 2.10 A, 
λmax abs = 501 nm vs. λmax ex = 485 nm) with a shape similar to that of the absorption 
spectrum of 2.1 in acidic buffer (see pH titration in Fig. 2.7). Interestingly, under these 
conditions, excitation near the absorption maximum resulted in little emission from 2.1 
indicating that the major component, 2.1 with the phenol ionized (pKa = 6.22), is strongly 
absorbing but with limited or no emission. The weak emission of 2.1 at these conditions 
is largely from the minor species.  
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Figure 2.9 Spectral properties of fluorescein and compound 2.1 (2.31 × 10-6 M in 0.1 M 
phosphate buffer pH 7.4) in absence and presence of Cys (10.0 mM). (A) Absorption 
spectra. (B) Emission spectra excited at 463 nm. The vertical line in (A) represents the 
wavelength chosen for excitation in (B). All spectra were collected at room temperature. 
Excitation and emission bandpass = 5 nm. 
 
The fluorescence intensity of the reaction product monitored over time at its 525 
nm emission maximum increased by ~41-fold as the excitation spectra shifted to more 
closely resemble the corresponding absorption spectra (reaction product λmax abs and λmax 
ex from Fig. 2.10 are both 499 nm). This indicates that emission of the dianion 
(carboxylate and phenolate both ionized) of the reaction product is not suppressed as it 
was for 2.1 in the absence of thiol. Differences between the absorption and excitation 
spectra of 2.1, combined with opposite shifts in the absorption and excitation spectra 
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(blue vs. red, respectively) as the Cys reaction product formed afforded a window of 
excitation wavelengths wherein the fluorogenic response could be maximized. The 
enhancement factor increased from as little as a few fold when excited near 400 nm to 
>40-fold when excited near 510 nm (Inset, Fig. 2.10 B). The optimized enhancement is 
much greater than the ~5-fold difference between the quantum yield of 2.1 (0.054) and 
the reaction product (0.289). 
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Figure 2.10 Spectral properties of compound 2.1 (9.38 × 10-7 M ) in the presence of Cys 
(10.0 mM). A) absorption spectra as a function of time (60 min). Inset: normalized 
absorption and excitation spectra of 2.1. B) excitation spectra monitored at the 525 nm 
emission peak of the reaction product as a function of time (60 min). Inset: fluorescence 
enhancement factor of compound 2.1 as a function of excitation wavelength. Vertical 
lines represent the optimized wavelength of 508 nm chosen for excitation of all 
subsequent emission spectra. All spectra were collected at rt. Excitation and emission 
bandpass = 5 nm. 
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 Interestingly, excitation wavelengths at (i) themax ex of 2.1, (ii) themax abs of 2.1, 
or (iii) within the spectral region which displayed the greatest increase in absorbance in 
response to Cys (~495 nm) did not result in the greatest fluorescence intensity 
enhancements. Therefore, these are not the best choices for excitation wavelengths as 
might initially be assumed. A well-defined isosbestic point in the absorption spectra was 
observed at 508 nm. Constant absorbance combined with this wavelength being (i) near 
the maximum in the excitation spectrum of the reaction product and (ii) in the region 
where the fluorescence enhancement was the largest was chosen as the excitation 
wavelength for all further experiments. 
2.3.3 Selective Detection of Cysteine and Homocysteine 
The fluorogenic response of 2.1 towards other thiols was investigated following 
optimization using Cys. Emission of 2.1 in the presence of various thiols (em = 524 nm 
upon excitation at 508 nm) demonstrated that compound 2.1 displayed selectivity towards 
specific biothiols of interest including Cys and Hcy (Fig. 2.11, see also complete 
emission and absorption spectra in Appendix Fig. B1). After the completed reaction, 2.1 
displayed 1.43-fold selectivity for Cys over Hcy as a result of different quantum yields of 
the reaction products 2.1-Cys = 0.289 vs2.1-Hcy = 0.202). The Cys reaction product forms 
at a faster rate resulting in selectivity over Hcy as great as ~2.9-fold early in the course of 
the reaction (Fig. 2.11 A, Fig. 2.12, Fig. B2 in Appendix). Importantly, the response of 
2.1 to Cys and Hcy was found to be linear with concentration (M – 1.0 mM). 
Selectivity towards Cys of greater than 2-fold was observed for concentrations as low as 
M (Fig. 2.12) and although not yet optimized, the limit of detection for Cys was 
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found to be ~3-fold lower than that of Hcy (M vs. M following 20 min of 
reaction, see Appendix Fig. B3). 
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Figure 2.11 Response of compound 2.1 to thiols (10.0 mM) of interest and their 
structural analogs. A) fluorescence emission at 524 nm. B) absorbance at the 508 nm 
excitation wavelength.* Signal still increasing after 2 h. C) Structures of targeting thiols 
and analogs for the mechanism study. Abbreviations: pen = penicillamine, cystea = 
cysteamine, L-ca = L-cysteic acid, 3-mpa = 3-mercaptopropionic acid, 2-me = 2-
mercaptoethanol.  
 
Close inspection of Fig. 2.11 reveals that a significant fluorogenic response 
results only from compounds containing both a free thiol and amine in which a thiazinane 
or thiazolidine heterocycle could form. The mechanism behind this selectivity was 
  2.1           2.1+       2.1+      2.1+      2.1+     2.1+       2.1+       2.1+        2.1+       2.1+
                 Cys        Pen     Cystea      L-ca        Ser        3-mpa    2-me        Hcy        Met 
C) 
  2.1           2.1+       2.1+      2.1+      2.1+     2.1+       2.1+       2.1+        2.1+       2.1+
                 Cys        Pen     Cystea      L-ca        Ser        3-mpa    2-me        Hcy        Met 
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investigated and confirmed through a series of structurally related analogs containing 
various functional groups and combinations thereof and through computer-assisted 
molecular modeling (vide infra). 
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Figure 2.12 Selectivity towards Cys over Hcy. Ratio of fluorescence emission (em = 524 
nm upon 508 nm excitation) of Cys and Hcy reaction products with 2.1 as they formed 
over time. 
 
  
Figure 2.13 Energy-minimized structures of the reaction products of 2.1 with Cys (left) 
and Hcy (right) showing the distance between the NH3+ and the phenolate groups. The 
electrostatic interactions between NH3+ and the carboxylate and/or phenolate groups of 
2.1 are influenced by increased ionic strength (addition of 1 M NaCl) resulting in a 
corresponding decrease in selectivity toward Cys (see Appendix Figures B4-B6).  
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Thiols attack the  carbon of aldehyde 2.1, thereby restoring xanthene emission. 
Once formed, the covalent complexes can undergo further interaction with the 
chromophore thereby affording increased selectivity by affecting the ionization state of 
the phenolic hydroxyl. Energy-minimized simulations (Sybyl 8.0, Tripos Inc.) indicate 
that for amino thiols in general at neutral pH, depending on the length of the alkyl chain, 
electrostatic interactions between the NH3+ group with both the phenolate and the 
carboxylate moieties of 2.1 occur (Fig. 2.13). 
In the case of Cys and Hcy there is a greater fluorescence response for the Cys-
adduct (Fig. 2.11, also see Appendix Fig. B1). The Cys side chain is shorter than that of 
Hcy, allowing the NH3+ group to more tightly bind the xanthene phenolate oxygen rather 
than the carboxylate, thereby directly enhancing fluorophore ionization and emission. In 
contrast, the alkyl chain in Hcy is longer allowing the NH3+ group to instead favor 
formation of a salt bridge with the carboxylate moiety of 2.1, which has a relatively 
minor effect on fluorophore moiety ionization (Fig. 2.13). In the case of thiols without 
cationic character, such as mercaptoethanol and mercatopropionate, emission is relatively 
lower as electrostatic interactions with the phenolate oxygen are relatively diminished. 
The observed trend in emission enhancement of 2.1 is thus Cys (40.98-fold) > Hcy 
(28.73-fold) > mercaptoethanol (6.04-fold) > mercaptopropionate (1.66-fold) after 
complete reaction with excess thiol (M compound 2.1 : 10.0 mM thiol). 
2.3.4 Site-specific Peptide and Protein Residue Detection 
The reaction of N-terminal cysteine residues with aldehydes has been applied to 
the site-specific modification, ligation, and labeling of peptides and proteins.34 The 
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selectivity of 2.1 for N-terminal cysteine-containing peptides is evidenced by observing 
the fluorescence emission in the presence of N- and C-terminal dipeptides (Fig. 2.14). 
In solutions containing 2.1 and Cys-Gly (an N-terminal cysteine dipeptide) or 
Glu-Cys (a C-terminal cysteine dipeptide), only the solution containing Cys-Gly exhibits 
significant fluorescence emission enhancement. A similar result is obtained for a solution 
of 2.1 and laminin-11 (a synthetic nonapeptide containing an N-terminal cysteine residue, 
also known as peptide 11). Laminin-11 has been used for the development of anti-
metastatic drugs.35 Interestingly, the reaction of 2.1 with N-terminal Cys-containing 
peptides affords greater signal enhancement compared to simple thiols. The greatest 
signal enhancement of all analytes resulted from the nonapeptide (Fig. 2.14, see also 
complete emission and absorption spectra in Appendix Fig. B7). Previously reported 
functional xanthenes36 that exhibit analyte-dependent emission based on an analogous 
combination of supramolecular and covalent interactions between sugar-derived boronate 
ester complexes and a rhodamine fluorophore also exhibit significantly enhanced 
emission in the presence of polysaccharides as compared to mono- and disaccharides.37 
We propose that this increased fluorescence from larger analytes is due to more 
complex non-covalent interactions and/or better shielding from solvent molecules, other 
fluorophores, or other potential sources of non-radiative decay including dynamic 
quenching by dissolved oxygen as compared to smaller analyte complexes. Further 
studies of the impact of probe-bound analytes on the spectral properties of fluorophores 
are currently underway in our laboratory. 
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Figure 2.14 Response of compound 2.1 to thiols (0.5 mM) and peptides (0.5 mM) of 
interest. A) fluorescence emission at 524 nm. B) absorbance at the 508 nm excitation 
wavelength.* Signal still increasing after 2 h. C) Structures of studying peptides. 
 
2.4 Experimental 
 Instrumentation 
All chemicals were purchased from Sigma-Aldrich and Cambridge Isotope Labs 
and used without further purification. NMR spectra were acquired in DMSO-d6 or 0.1M 
pH 7.4 phosphate buffer/D2O (9:1) on a Bruker AMX-400 NMR spectrometer. ESI-
HRMS (high-resolution mass spectrometry) spectra were obtained at a Thermo Electron 
LTQ Orbitrap hybrid mass spectrometer and a Waters Micromass Q-TOF micro (ESI-Q-
 2.1               2.1+Hcy           2.1+Cys        2.1+Cys-gly     2.1+Laminin     2.1+Glu-cys 
C) 
 2.1               2.1+Hcy           2.1+Cys        2.1+Cys-gly     2.1+Laminin     2.1+Glu-cys 
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TOF). UV-visible measurements were collected on a UV-Vis Cary 50 and Fluorescence 
spectra were collected on Cary Eclipse (Varian, Inc.). 
 Synthesis of Fluorescein Monoaldehyde5 
Fluorescein (2.5 g, 7.75 mmol) and 3 mL of MeOH were placed in a 100 mL 
three-neck round-bottom flask and 10 g of a 50% NaOH solution along with 0.03 mL 15-
crown-5 were added. 2.42 mL (30 mmol) CHCl3 was added dropwise while maintaining 
at 55 °C temperature. The mixture was stirred at this temperature for 5 h. After cooling, 
the mixture was acidified with 10 M H2SO4 and the product precipitated. The solid was 
filtered and dried in vacuo overnight. Chromatography on silica gel (15:85 EtOAc:DCM) 
yielded a light yellow solid, 910 mg (32.6%). Rf =0.28 (15:85 EtOAc:DCM). 1H NMR 
(400 MHz, DMSO-d6) δ (ppm): 11.87 (s, 1H), 10.63 (s, 1H), 10.24 (s, 1H), 8.01 (d, J = 
7.4 Hz, 1H), 7.77 (dtd, J = 30.1, 7.4, 1.1 Hz, 2H), 7.31 (d, J = 7.6 Hz, 1H), 6.94 (d, J = 
8.9 Hz, 1H), 6.84 (d, J = 1.9 Hz, 1H), 6.70 (d, J = 8.9 Hz, 1H), 6.61 (d, J = 2.2 Hz, 2H). 
 Synthesis of Compound 2.1 (-unsaturated Monoaldehyde Fluorescein) 
To a solution of monoaldehyde (144 mg, 0.4 mmol) in CHCl3 (25 mL), 
triphenylphosphoranylidene acetaldehyde (152 mg, 0.5 mmol) was added resulting in a 
red solution. The mixture was stirred at 50 ºC under N2 for 24 h, cooled to rt and the 
solvent removed in vacuo. Chromatography on silica gel (10:90 MeOH:DCM) yielded 
compound 2.1 (94.7 mg, 61.3%) as a red solid. 1H NMR (400 MHz, 0.1M pH 7.4 
phosphate buffer/D2O 9:1) δ (ppm): 9.29 (d, J = 8.4 Hz, 1H), 7.97 (d, J = 15.8 Hz, 1H), 
7.78 (dd, J = 5.7, 3.3 Hz, 1H), 7.63 (dd, J = 5.7, 3.3 Hz, 2H), 7.30 (dd, J = 5.7, 3.3 Hz, 
1H), 7.24 (dd, J = 15.8, 8.4 Hz, 1H), 7.09 (dd, J = 19.1, 9.5 Hz, 2H), 6.65 (d, J = 2.1 Hz, 
1H), 6.59 (dd, J = 9.2, 2.1 Hz, 1H), 6.44 (d, J = 9.5 Hz, 1H). 13C NMR (101 MHz, 0.1M 
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pH 7.4 phosphate buffer/D2O 9:1) δ (ppm): 199.69, 180.57, 179.09, 175.00, 158.86, 
157.77, 157.58, 147.77, 139.48, 132.71, 131.20, 131.07, 130.01, 129.70, 129.44, 128.37, 
127.11, 123.93, 123.17, 112.61, 111.77, 109.68, 103.51. ESI-FTMS m/z = 385.0706 [M-
H]-, calc. 385.0718 for C23H14O6. 
 Preparation of the Reaction Product of Compound 2.1 with Thiol/Analogs 
Freshly prepared solutions of cysteine or homocysteine (200 μM – 20 mM in 
0.1M pH 7.4 phosphate buffer) were mixed with solutions of compound 2.1 (2 or 4 μM in 
0.1M pH 7.4 phosphate buffer) in a 1:1 volume ratio at room temperature. Other thiols 
and analogs (20 mM in 0.1M pH 7.4 phosphate buffer) and peptides (1 mM in 0.1M pH 
7.4 phosphate buffer) were mixed with solutions of compound 2.1 (2 μM in 0.1M pH 7.4 
phosphate buffer) in a 1:1 volume ratio at room temperature. 
2.5 Conclusions 
We have synthesized a new fluorogenic dye that displays signal amplification in 
the presence of biothiols. Fluorescence signaling in the presence of analytes of interest 
including Cys, Hcy, and N-terminal cysteine peptides was observed to be in excess of 40 
times that of compound 2.1 alone. The fluorescence intensity was directly proportional to 
the analyte concentration and a greater than 2-fold selectivity towards cysteine over 
homocysteine was achieved. Importantly, compound 2.1 did not respond to structurally 
similar analogs. Additionally, fluorescence resulting from the reaction of 2.1 and N-
terminal cysteine dipeptides and larger peptides was observed to be greater than upon 
reaction with simple thiols. The design of new dyes to attain specific signal transduction 
in the presence of bioactive analytes is ongoing. 
*Reproduced by permission of The Royal Society of Chemistry 
http://pubs.rsc.org/en/content/articlelanding/2010/cc/c0cc01398f
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CHAPTER 3.  DETECTING SPECIFIC SACCHARIDES VIA A SINGLE 
INDICATOR 
 
3.1 Introduction: Excitation-Emission Matrices (EEM) 
 Fluorescence is generally measured at one excitation wavelength, and analyzed by 
the signal response to an analyte of interest at the corresponding emission wavelength 
(see Chapter 2). Typically, experimental conditions including excitation wavelengths and 
emission ranges are somewhat arbitrarily chosen when developing a sensor system. 
Excitation near the absorption maximum of a dye in buffer solution without interferences 
or the analyte of interest is often used. However, relying on the absorption maximum of 
an indicator in a simple buffer may not be optimal for attaining selectivity towards an 
analyte of interest. For example, the optimum excitation wavelength for fluorogenic α,β-
unsaturated monoaldehyde was found to be different than the maximum absorption 
(Chapter 2).  
Changing the excitation wavelength or analyzing the data in a different emission 
region may improve the selectivity of the signal generation. When measuring the 
fluorescence of a sample at several different excitation wavelengths for several emission 
wavelengths, an excitation-emission matrix (EEM) is obtained. An EEM contains 
detailed information about samples in two-dimensional data matrices. EEMs are also 
used for bioprocess samples monitored both qualitatively and quantitatively. Recent and 
ongoing work uses this principle.  
3.2 Background 
3.2.1 Simple Optical Indicators for Chemosensing 
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The development of simple optical indicators is of great current interest for the 
detection of small molecule disease biomarkers.38  Selective detection is usually 
attributed to the distinctive interaction between the analyte and indicator or receptor. 
However, several indicator-biomolecule complexes may co-exist in a dynamic 
equilibrium. This is particularly relevant in complex natural sample matrices and wherein 
supramolecular or reversible covalent interactions are the basis of the analyte-selective 
signaling.  
Although the presence of a variety of indicator-bound species may hinder 
selective detection, the structural differences between the various complexes may afford 
distinctive absorption and emission profiles, thereby potentially allowing for multiple 
analyte detection via a single optical indicator. Herein we describe how judicious 
selection of specific excitation and emission wavelengths allows one to use a single 
indicator dye for the tunable detection of specific saccharides. The use of wavelength 
switching, rather than indicator or receptor structure changes, embodies a relatively 
streamlined approach to chemosensing. 
3.2.2 Development of Rhodmine Boronic Acid Dye 
Xanthene dyes such as fluorescein and rhodamine derivatives are the most 
commonly-used fluorescent dyes due to their bright fluorescence and compatibility with 
common laser line excitations. Fluorescein emission generally falls in the green or yellow 
spectral region while some rhodamines exhibit red emission (> 600 nm).  
In 2006 the Strongin group published the first report of a rhodamine boronic acid 
(reversibly-covalent) indicator 3.1 (Fig. 3.1) that was more selective for ribose, 
adenosine, nucleosides and nucleotides (including AICAr, the commercially available 
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model succinylpurine metabolite for the rare autism spectrum disorder ADSL deficiency) 
as compared to fructose, the compound for which typical boronic acid compounds are 
inherently selective.36 
 
 
Figure 3.1 Rhodamine boronic acid 3.1 and ribose and ribose-containing target 
molecules. 
 
Probing the mechanism for attaining unique selectivity towards ribose and 
congeners using 3.1 as a platform has been of ongoing interest in our labs. This effort is 
to aid the design of indicators for specific nucleosides as well as thiol-derived 
biomarkers39 of methylation status and oxidative stress (e.g., SAM and SAH).40  
According to very strong preliminary results, as well as more recent mechanistic 
studies, rhodamine modified with a phenyl boronic acid can exhibit unprecedented 
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affinity for ribose and similar compounds as compared to fructose.36 Computer assisted 
molecular simulations suggest that apart from the preference of the boronic acid to react 
with the 2,3-cis diol of the furanose form of ribose and the strong electrostatic interaction 
B--O---H-N+, non-covalent secondary interactions play an important role in modifying 
the ionization state of the chromophore. Charged H-bonding can occur between the 
nucleosides and the dye carboxylate. This is a critical feature in determining selectivity; 
when the carboxylate is esterified in the rhodamine boronic acid dye, it reverts to fructose 
selectivity (Fig. 3.2). 
 
 
Figure 3.2 Energy-minimized model of the boronate ester formed after condensation of 
one equivalent of a nucleoside (AICAr) to 3.1. Color atom codes: B = yellow, C = white, 
N = blue, O = red, H = cyan. Only hydrogen atoms involved in H-bond formation are 
displayed for simplicity. Dashed lines represent distance in angstroms. 
 
3.3 Results and Discussion 
3.3.1 Microwave Assisted Synthesis of Rhodamine Boronic Acid 
An improved synthesis of a rhodamine boronic acid indicator was developed. A 
one-pot microwave-assisted synthesis was used for the preparation of 3.1, in a reductive 
amination procedure. Conversion to 3.1 occurs with better yield (70 %) and reaction time 
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(20 min compared to > 24 h previously).41 The one-pot microwave-assisted reaction 
product is purified via simple filtration rather than via the previously reported 
chromatographic methods (Scheme 3.1). 
 
Scheme 3.1 Microwave-assisted reaction of compound 3.1. 
3.3.2 Time and Wavelength Dependent Detection of Multiple Analytes 
Previously the selectivity of rhodamine boronic acid 3.1 for ribose was measured 
via fluorescence excitation at 565 nm. We have shown that the small non-specific 
interference from fructose signal in this wavelength region can be removed via the 
addition of non-fluorescent boronic acid derivatives.36  
However, we surprisingly found wavelength-dependent selectivity of 3.1 for 
different sugars and ribosides through EEMs obtained in the excitation range from 470 to 
620 nm and in the emission range from 520 to 690 nm. Fructose promotes a selectively 
high intensity at 510 nm, whereas AICA-riboside promotes relatively low signals (Fig. 
3.3). These data are also time-dependent and display the different selectivities of 3.1 
when monitored over time. For example, compound 3.1 responds to fructose in a 
different spectral region than ribose-derivatives, i.e. near 550 nm when excited at shorter 
wavelength near 510 nm in a time dependent manner with the peak increasing over time. 
When plotted as a function of time at an excitation wavelength of 510 nm, ribose 
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derivative-3.1 solutions do not exhibit significant emission responses in this region (Fig. 
3.4). 
 
Figure 3.3 Emission spectra demonstrating selective response to various analytes. (top) 
Control, AICAr and fructose emission spectra at given excitation wavelengths (510 or 
570 nm) and times (31 or 58 min) after mixing. (bottom) Control, SAM, and SAH 
emission spectra upon excitation at 560 nm and 11 min after mixing. Final concentration 
of 3.1 was 20M with each analyte at a concentration of M in 90% DMSO : 10% 
25 mM pH 7.5 phosphate buffer. One part aqueous analyte was added to 9 parts 3.1 in 
DMSO followed by 15 sec vortexing. EEMs were collected sequentially every 4 min for 
1 h. 
 
Fig. 3.3 demonstrates that 3.1 displays an increased response toward both AICAr or 
fructose as a function of time and wavelength. It also shows the selectivity of 3.1 for 
SAM versus SAH. The ratio of SAM:SAH is frequently used as an indicator of cellular 
methylation potential.40 Interestingly, SAM and SAH can be distinguished from AICAr 
by a wavelength shift of approximately 10 nm in both excitation and emission (ex=560 
nm, em=587.5 nm) as can be seen in the contour plots of these analytes in Fig. 3.5. 
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Figure 3.4 Intensity as a function of time. (top) Control, AICAr and fructose emission at 
597.5 nm upon excitation at 570 nm. (center) Control, AICAr and fructose emission at 
552.5 nm upon excitation at 510 nm. (bottom) Control, SAM, and SAH emission at 587.5 
nm upon excitation at 560 nm.  
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3.3.3 Multiple Analyte Detection via a Single Indicator 
Solutions of 3.1 containing various analytes, when monitored over time at several 
different excitation and emission wavelengths, afford us large multidimensional data sets 
specific for various analytes. Accordingly, the observation makes the specific detection 
of fructose, in addition to ribose derivatives, possible with this probe. Data were collected 
as EEMs as a function of time. From this large multidimensional data set, spectra can be 
extracted at a specific times or the intensity at a specific wavelength monitored as a 
function of time. These data provide specific analyte dependent features such as the 
excitation and emission wavelengths resulting in the greatest signal and the time at which 
this signal occurs.  
A subset of this data is presented in Fig. 3.5. According to the contour plots of 
excitation-emission matrices (EEMs) obtained in the excitation range 470 to 620 nm and 
emission range from 520 to 690 nm, solutions of 3.1, and 3.1 with various analytes, 
display patterns which are distinguishable for each analyte. There are differences in 
fluorescence intensity; however, there are also clearly different spectral signatures. Fig. 
3.5 reveals a relatively higher emission response for the AICA-riboside and SAM as 
compared to fructose in the emission region near 600 nm when excited near 565 nm.  
The most dramatic example of time and wavelength dependent detection in using a 
single indicator is shown in Fig. 3.6. It is constructed simply by scanning the EEM of 
each solution every 4 min for 1 h. One can visually distinguish each of the analyte-3.1 
solutions qualitatively (Fig. 3.6 A).  
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Figure 3.5 EEMs demonstrating the response of 3.1 towards various analytes.  (A) 3.1 at 
31 min, (B) 3.1 plus AICAr at 31 min, (C) 3.1 plus fructose at 58 min, and (D) 3.1 plus 
SAM at 11 min. The x-axis represents emission wavelength while the y-axis is excitation 
wavelength such that vertical and horizontal slices represent typical excitation and 
emission spectra respectively. Excitation and emission step sizes of 10 nm and 5 nm, 
respectively with a bandpass of 5 nm for each. Fluorescence intensity is represented on 
the z-axis as various colors.  
 
Initial results also indicate that the system will function in a more complex 
setting, i.e. when two analytes are present at the same time. As proof of concept, mixtures 
of two analytes (fructose and AICAr) were investigated. Sample mixtures enriched in 
either AICAr or fructose display signatures of both individual analytes but with features 
of the major analyte more dominant. Although the response is complicated, advanced 
data processing (i.e. chemometrics) should simplify interpretation. Efforts to quantify 
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mixtures are ongoing. Work is also ongoing to better understand the dynamic processes 
including supramolecular and reversible covalent interaction involved in these unique 
analyte dependent signals and their changes over time. Our previous studies attributed the 
selectivity of the compound 3.1 emission upon excitation at 565 nm to the fact that its 
ribose complex can exhibit tighter binding to the fluorophore as compared to the 
corresponding fructose and glucose complexes.36 Simulations showed that this can occur 
via a charged hydrogen bond to the carboxylate moiety of 3.1. Favorable ion pairing 
interactions are thus likely responsible for the differences in the response of 3.1 toward 
positively charged SAM vs. neutral SAH. Energy minimization studies afford an 
analogous explanation for the selectivity for AICAr over fructose (570 nm excitation, 
Fig. 3.3) that involves AICAr-3.1 extended intramolecular interactions of the 
aminoimidazole carboxamide moiety with both, the carboxylate oxygen and the 
remaining free boronic acid (Fig. 3.2).  
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Figure 3.6 Time and wavelength dependent detection. (A) EEMs of control and 3.1 plus 
100 μM of analyte. (B) EEMs of 3.1 plus fructose and AICAr mixtures. Total 
concentration of each analyte mixture is 100 μM. The ratio of fructose to AICAr is 
increased toward the right as indicated. The first EEM in time is plotted at the bottom 
with time increasing toward the top.  
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3.4 Experimental  
 
 Instrumentation 
All chemicals were purchased from Sigma-Aldrich and Cambridge Isotope Labs 
and used without further purification. Microwave synthetic procedures were performed in 
an Initiator™ microwave synthesizer (Biotage). NMR spectra were acquired on a Bruker 
AMX-400 NMR spectrometer. High-resolution mass spectrometry spectra were obtained 
from the Georgia State University Mass Spectrometry Facility. Absorbance spectra were 
collected on a Cary 50 UV-Vis spectrophotometer and Fluorescence spectra were 
collected on Cary Eclipse fluorescence spectrophotometer (Agilent Technologies). HPLC 
was carried out using a Nova Pak C18 300 Å, 4 µm, 3.9 × 150 mm (Waters, USA) 
column on a Waters 1525 Binary pump equipped with a Waters 2996 Photodiode Array 
Detector. 
 Synthesis of Compound 3.1, Rhodamine (bis) Boronic Acid ((E)-2-(6-((2-
boronobenzyl)amino)-3-((2-boronobenzyl)imino)-3H-xanthen-9-yl)benzoic 
acid). 
 
Rhodamine 110 (45 mg, 0.136 mmol), 2-formylphenyl boronic acid (100 mg, 
0.667 mmol), sodium triacetoxyborohydride (90 mg, 0.425 mmol) and CH3CN (1.7 mL) 
were mixed in a microwave vial (max. capacity: 2.0 mL, Biotage) containing a magnetic 
stir bar. Concentrated acetic acid (50 µL, 52 mg, 0.873 mmol) was then added and the 
vial sealed with a microwave proof cap (Biotage). The vial was stirred and irradiated 
while keeping the temperature at 130 ºC for 20 min. The vial then cooled to rt and the cap 
removed. The reaction mixture was quenched with saturated NaHCO3 aqueous solution 
and extracted in EtOAc, dried with anhydrous Na2SO4 and filtered. The solvent was 
removed in vacuum to yield a dark red solid. Yield: 57 mg (70%). 1H NMR (400 MHz, 
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CD3OD) δ (ppm):, 7.52-7.65 (m, 3H), 7.36-7.48 (m, 3H), 7.06-7.35 (m, 10H), 6.69 (m, 
1H), 5.90 (s, 1H), 5.02 (s, 4H). 13C NMR (101 MHz, CD3OD) δ (ppm) 173.02, 155.33, 
134.72, 133.31, 132.25, 131.82, 131.39, 131.25, 130.99, 130.28, 129.61, 128.88, 128.07, 
125.18, 123.96, 122.19, 117.40, 72.33. HRMS ESI-FTMS m/z = 599.2087 [M+H]+, 
calcd. 599.2161 for C34H29B2N2O7. 
3.5 Conclusions 
We have developed an improved synthesis of 3.1 via a microwave-assisted 
reductive amination and an optimal data collection method for wavelength-time 
dependent selectivity via EEMs. The results herein show that it is possible to use such 
data sets to develop strategies for allowing one indicator to be used to selectively 
distinguish structurally related sugar analytes. The dramatic advantage of time and 
wavelength dependent detection is using one sensor for selectivity of multiple analytes 
simultaneously with saving time and materials. Further understanding the equilibria 
involved which lead to this wavelength dependent selectivity and better taking advantage 
of the tremendous amount of information contained in these large data sets are ongoing in 
our group. 
 
 
 
 
 
 
 
 
 
 
 
 
*Reproduced by permission of The Royal Society of Chemistry 
http://pubs.rsc.org/en/content/articlelanding/2011/cc/c1cc11343g 
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CHAPTER 4.  PROGRESS TOWARDS SIMPLE AND DIRECT DETECTION OF 
ADENYLOSUCCINATE LYASE DEFICIENCY IN HUMAN URINE 
 
The rhodamine boronic acid fluorophore described in the previous chapter 
linearly responds to increasing 5-aminoimidazole-4-carboxamide riboside (AICAr) 
concentrations in buffer solution. In this chapter an advance in detecting 
adenylosuccinate lyase deficiency in natural media, using AICAr is a model for the 
ADSL substrates succinyladenosine (S-Ado) and succinylaminoimidazolecarboxamide 
riboside (SAICAr) is described.  
Adenylosuccinate lyase (ADSL) deficiency is a rare but devastating disease of de 
novo purine synthesis in infants. Its diagnosis is also significant as it is one of the autism 
spectrum disorders (ASDs). Our experience in the selective detection of sugars and 
ribosides has resulted in progress towards a simple test for these infants who excrete 
massive (mM levels), of SAICAr and S-Ado in their urine. These tests would also serve 
to guide development of other nucleoside and nucleotide indicators for the detection of 
other diseases such as cancer. 
4.1 Background 
4.1.1 Global Demands of Simple Diagnostic Tests 
There is a global need for more simple, reliable and inexpensive diagnostic tests 
in patient samples. In the US and other developed nations, there is growing interest in 
point-of-care and personalized medicine. At a 2008 AAAS symposium entitled “High-
Tech, Low-Cost Medicine: A New Paradigm for Global Health,” medical practitioners 
and researchers emphasized that significant effort is still needed towards the creation of 
practical diagnostic devices. According to Whitesides, “the first-world health care system 
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is too expensive. We need better ways of anticipating and forestalling disease to address 
the problem before it becomes something that consumes enormous resources”.17 A major 
expected outcome of my research is new inexpensive and reliable diagnostics via creating 
a new class of fluorophores that function in challenging media and functionalizing the 
new dyes appropriately to achieve simple prototype indicators.  
The current clinical chemistry technologies require significant sample preparation 
and handling for the analysis of complex biological samples. Sample preparation remains 
a big issue in simplified diagnostics. One approach receiving a great deal of current 
attention uses highly integrated miniaturized diagnostic devices that incorporate sample 
fractionation and purification components into microfluidic paper.42 However, 
recognition and signaling elements are often comprised of relatively fragile and 
expensive biological materials such as antibodies and enzymes.  
The “gold standard” in user friendly diagnostics is often considered to be the 
home pregnancy test, which consists of lateral flow technology and a biological 
recognition element. There are formats wherein using biotic recognition elements are of 
great utility and impact. However, in general, synthetic materials are less expensive and 
more robust. It has been noted by Lakowicz that indicator fluorophores for specific 
biomarkers which may function directly in the analyte’s medium without sample 
handling or separation steps require “fewer manipulations, resulting in fewer sources of 
error, shorter times to results, and reduced health hazards due to the handling of 
samples”.43 However, surprisingly little progress has been made in this area. A goal of 
this project is to create useful new prototype disease indicators which function in 
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complicated sample matrices with minimal sample preparation for use in settings that do 
not require highly trained personnel or elaborate equipment. 
4.1.2 Adenolosuccinate Lyase (ADSL) Deficiency  
Devastating inborn errors of purine metabolism such as adenolosuccinate lyase 
(ADSL) deficiency are very serious disorders that are generally under-diagnosed. 
According to a very recent (2009) review,44 genetic defects in purine and pyrimidine (PP) 
metabolism may often be misdiagnosed or remain undiagnosed. Dysfunction in PP 
metabolism may affect any system in a variety of manners, and often mimic other, more 
recognizable disorders. If undiagnosed, these disorders can be devastating to patients and 
their families, resulting in early death or institutionalization for the rest of the patient’s 
life.  
ADLS deficiency is a rare (approximately 1 in 200,000) inborn error of purine 
metabolism first reported in 1984 in a group of children patients with hereditary 
psychomotor retardation, autism and seizure.6 Manifestations include mental retardation, 
congenital blindness, epilepsy, and dysmorphism. It is recommended that routine 
screening for ADSL deficiency be done in all cases of psychomotor retardation, and in 
neurologic disease with convulsions and hypertonia. ADSL deficiency can be an under-
diagnosed metabolic disorder which should be included in the screening program of 
metabolic investigations, in all infants with unexplained neonatal seizures, severe 
infantile epileptic encephalopathy, developmental delay, hypotonia, and/or autistic 
features.45 This disorder is characterized by urinary excretion of succinyl-5-amino-4-
imidazolecarboxamide riboside (SAICAr) and succinyladenosine (S-Ado), the 
nucleosides corresponding to SAICA-ribotide (SAICAR) and adenylosuccinate.  
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Figure 4.1 ADSL deficiency biomarker SAICAr and S-Ado. 
Initially testing for ADSL deficiency via SAICAr and S-Ado identification relied 
on separations since the Bratton-Marshall test is a non-specific reaction leading to a high 
rate of false positives. TLC has most recently been used46 and recommended6 as a simple 
screening method for these metabolites; however, it relies on the Pauly reagent for spray 
visualization. The Pauly reagent is diazotized sulfanilic acid. It has been noted as 
explosive, and needs fresh preparation prior to use. It is thus not amenable to point-of-
care or personalized medicine, and necessitates analyte separation. We propose 
developing stable and selective reagents for SAICAr and S-Ado that will function in 
urine and not require separations. The hypothesis is benzoxanthene dyes functionalized 
with covalent and supramolecular binding sites targeted for specific nucleosides can 
serve as simple indicators for adenylosuccinate lyase deficiency.  
4.2 An Application of Multidimensional Measurements to Biological Media 
Multidimensional fluorescence measurements have been widely used in clinical 
analysis,47, 48 food science,49 and environmental analysis.50 Excitation-emission matrices 
(EEMs) in which the fluorescence response of a sample is monitored at multiple emission 
wavelengths upon excitation at multiple different wavelengths have a greater information 
content as compared to more conventional emission spectra collected upon excitation at a 
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single wavelength. This greater information content allows for characterization or 
determination of substances in complex multi-component mixtures or samples in 
biological media with a complex background, i.e. methotrexate in urine,47 or salicylate in 
plasma samples.48 
Previously we employed the multidimensional nature of fluorescence in the 
detection of multiple disease biomarkers using a single indicator via an optimized data 
collection protocol which scanned EEMs monitoring the indicator's time- and wavelength 
dependent response every 4 min for 1 h (Chapter 3). Upon further investigation it was 
discovered different biomarker analytes displayed distinct time- and wavelength-
dependent spectral features. For example, the indicator was shown to simultaneously 
respond to both fructose and a ribose nucleoside (5-aminoimidazole-4-carboxamide 
riboside) in mixtures with the response of each occurring in characteristically different 
spectral regions (Chapter 3). This raises the possibility of detecting an important ribose-
containing biomarker in more complex biological media containing many potential 
interferences. 
4.3 Results and Discussion 
Herein we investigate the feasibility of using 3.1 for the detection of 5-
aminoimidazole-4-carboxamide riboside (AICAr) in human urine. AICAr is a 
dephosphorylated form of AICAR (AICA-ribotide, also known as ZMP) that is 
biomarker of purine biosynthetic pathway disorder, AICA-ribosiduria.51 It is also a 
commercially available surrogate of succinyladenosine (S-Ado) and SAICAr which 
accumulate at extremely high mM levels in urine of adenylosuccinate lyase (ADSL) 
deficient patients.52 Some chromatographic techniques such as TLC, GC-MS or HPLC 
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are currently used for detection,44 but simple and improved methods to detect elevated 
level of S-Ado and SAICAr at physiologically relevant concentrations (mM in ADSL 
deficient as compared to undetectable levels in that of healthy groups) directly in urine of 
potentially ill patients without the need for separations or sample processing are desired.  
 
Figure 4.2 Rhodamine boronic acid 3.1 and AICAr. 
  Rhodamine boronic acid 3.1 responds to increasing AICAr concentrations with 
increased fluorescence emission near 590 nm upon excitation in the region of 560-570 
nm (Fig. 4.3). Increasing concentrations of buffered aqueous AICAr solutions were added 
to DMSO solutions of 3.1 such that the final solvent composition was 90% DMSO: 10% 
25 mM pH 7.5 phosphate buffer with a final dye concentration of M and AICAr 
ranging from 0-200M. It is clear the fluorescence intensity increased linearly as the 
concentration of AICAr increased. Regression analysis (inset Fig. 4.3 D) of Intensity vs. 
AICAr concentration yielded a straight line (y = 5.1822x + 66.453; R2 = 0.983) with a 
limit of detection of ~20M, three orders of magnitude below SAICAr and S-Ado 
concentrations in the urine of ADSL deficient patients. 
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Figure 4.3 EEMs and emission spectra demonstrating the responses of 3.1 to AICAr at 8 
min after mixing in a simple 10% buffer: 90% DMSO solvent system. Clockwise from 
top-left: (A) 40M 3.1, (B) 3.1 plus 200M AICAr, (C)Intensity, B minus A, (D) 
emission spectra as a function of AICAr concentrations when excited at 560 nm and 
linear regression (inset). White lines in A and B represent the excitation wavelength and 
emission range for spectra plotted in D. White circle in C represent the data point used 
for the regression analysis in D. 
 
3.1 also responds to increasing AICAr in a biological matrix, i.e. human urine 
(Fig. 4.4). Because (i) the limit of detection for AICAr in an ideal solvent system 
containing no interferences is much lower than required, and (ii) urine contains many 
potential interferences and possible quenchers of the fluorescence signal which makes it a 
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difficult matrix to work in, diluted samples containing 5% human urine were chosen as a 
starting point for investigation in this proof of concept. It is clear from Fig. 3a that the 
indicator responds strongly in the short wavelength region (emission near 540 nm upon 
excitation near 510 nm) to unidentified interferences present in the urine sample. This 
region, however, is far removed from the spectral region where the indicator responds to 
AICAr (emission near 590 nm upon excitations in the region of 560-570 nm). It is 
interesting to note that response in the short wavelength region is similar to that which 
was previously reported for fructose.4 Comparison of Fig. 4.4 A and 4.4B demonstrates 
increased in long wavelength emission for an AICAr-spiked urine sample. Intensity plots 
(Fig. 4.3 C and 4.4 C) are very similar in shape for the system containing only buffer and 
that containing urine and its associated interferences. 
When increasing concentrations of buffered aqueous AICAr solutions were 
combined with healthy human urine and added to DMSO solutions of 3.1 such that the 
final solvent composition was 90% DMSO: 5% 25 mM pH 7.5 phosphate buffer: 5% 
urine with a final dye concentration of M and AICAr ranging from 0-M, the 
longer wavelength fluorescence signal was observed to increase. Regression analysis 
(inset Fig. 4.4 D) ofIntensity vs. AICAr concentration in the long wavelength region 
yielded a straight line (y = 0.5557x + 8.8252; R2 = 0.982). The short wavelength region 
was not sensitive to the addition of AICAr (Fig. 4.4 E). Concentrations noted in Fig. 4.4 
correspond to AICAr levels above undiluted healthy urine ranging from 0.25 – 4.0 mM. 
A similar detection limit of ~20M was observed which corresponds to detecting 0.4 
mM AICAr above that of healthy human urine. 
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Figure 4.4 EEMs and emission spectra demonstrating the responses of 3.1 to AICAr at 
20 min after mixing in 5% healthy human urine: 5% buffer: 90% DMSO. Clockwise 
from top-left: (A) 40M of 3.1 in presence of 5% urine, (B) 3.1 in presence of 5% urine 
plus M AICAr, (C) Intensity, B minus A, (D) emission spectra as a function of 
AICAr concentrations when excited at 560 nm and linear regression (inset). (E) emission 
spectra as a function of AICAr concentrations when excited at 520 nm. White lines in A 
and B represent the excitation wavelength and emission range for spectra plotted in D. 
White circle in C represent the data point used for the regression analysis in D. 
 
These results provide a method to screen for elevated AICAr in a urine sample 
without the need for separation or sample processing. Work is ongoing to improve the 
quantification of AICAr with calibration tools such as PARAFAC.48, 53  Data processing 
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combined with normal standard addition protocols should allow efficient extraction of the 
analyte response distinct from interferences and indicator background signals.  
4.4 Experimental 
 Instrumentation 
All chemicals were purchased from Sigma-Aldrich and used without further 
purification. Normal human urine was purchased from Innovative research. Compound 
3.1 was prepared via microwave–assisted synthesis according to procedures reported 
earlier.54 An Initiator™ microwave synthesizer (Biotage) was used. Fluorescence spectra 
were measured on Varian Cary Eclipse fluorescence spectrophotometer (Agilent 
Technologies). EEMs were collected every 4 min for 1 hr; excitation at 470 – 620 nm 
each 10 nm, emission at 520 – 690 nm each 2.5 nm, both bandpass = 5 nm. EEM data 
were processed in MATLAB Version 7.9.0 (R2009b). 
 Preparation of the Reaction Product 
Dye was dissolved in DMSO and either buffered AICAr solutions or healthy 
human urine spiked with buffered AICAr was added. One part buffer or aqueous 
buffer/urine was added to 9 parts dye in DMSO. All samples were vortexed for 15 sec 
before fluorescence scanning.  
4.5 Conclusions 
We have demonstrated the ability to detect elevated levels of AICAr, a 
commercially available surrogate of S-Ado and SAICAr, in healthy human urine. This is 
a step towards a simple screen for elevated S-Ado and SAICAr. 
 
*Reproduced by permission of Australian Jornal of Chemistry 
http://www.publish.csiro.au/paper/CH11328.htm 
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APPENDIX A. CHARACTERIZATION DATA FOR COMPOUND 2.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1. 1H NMR of compound 2.1 
(400 MHz, 0.1 M pH 7.4 phosphate buffer/D2O 9:1) 
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Figure A2. 13C NMR of compound 2.1 
(101 MHz, 0.1 M pH 7.4 phosphate buffer/D2O 9:1) 
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Figure A3. ESI-FTMS of compound 2.1 
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Figure A4. ESI-TOF HRMS of complex of 2.1 with Cys. m/z = 609.0992 
[M-H]-, calc. 609.1007 for C29H26N2O9S2 
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APPENDIX B. SELECTIVE FLUORESCENCE DETECTION OF CYSTEINE 
AND N-TERMINAL CYSTEINE PEPTIDE RESIDUES 
 
 
 
 
 
Figure B1. Response of compound 2.1 to thiols of interest and structural analogs (10.0 
mM). (top) emission spectra excited at 508 nm (60 min). (bottom) absorbance spectra (60 
min). The vertical line represents the 508 nm excitation wavelength. 
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Figure B2. Evolution of fluorogenic response. Emission at 524 nm upon 508 nm 
excitation of 1 M 2.1 in the presence of excess thiols of interest and their structural 
analogs (10.0 mM). 
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Figure B3. Fluorescence response of 2.1 to Cys and Hcy as a function of time and 
concentration. (top) Evolution of fluorogenic response. 1 M 2.1 in the presence of 
excess Cys and Hcy (em = 524 nm upon excitation at 508 nm). Filled symbols and solid 
lines = Cys. Open symbols and dashed lines = Hcy. (bottom) Linear response of the 
fluorescence intensity as a function of thiol concentration (0 - 1000 M) after 22 min of 
reaction time. The limit of detection for Cys was ~3-fold lower than that of Hcy (39 M 
vs. 114 M). 
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Figure B4. Effect of salt on the response of compound 2.1 to excess (10.0 mM) Cys and 
Hcy in buffered solution (0.1 M phosphate pH 7.4) with and without additional NaCl (1 
M). (top) emission spectra excited at 508 nm (60 min). (bottom) absorbance spectra (60 
min). The vertical line represents the 508 nm excitation wavelength. 
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Figure B5. Effect of salt on the evolution of fluorogenic response. Emission at 524 nm 
upon 508 nm excitation of 1 M 2.1 in the presence of excess (10.0 mM) Cys and Hcy in 
buffered solution (0.1 M phosphate pH 7.4) with and without additional NaCl (1 M). 
 
 
 
 
Figure B6. Effect of salt on the selectivity towards Cys over Hcy. Ratio of fluorescence 
emission (em = 524 nm upon 508 nm excitation) of Cys and Hcy reaction products with 
2.1 (1 M 2.1 : 10 mM thiols) as they formed over time in buffered solution (0.1 M 
phosphate pH 7.4) with and without additional NaCl (1 M). 
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Figure B7. Response of compound 2.1 to thiols (0.5 mM) and peptides (0.5 mM) of 
interest. (top) emission spectra excited at 508 nm (60 min). (bottom) absorbance spectra 
(60 min). The vertical line represents the 508 nm excitation wavelength. 
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APPENDIX C. COMPUTATIONAL PROCEDURES OF ENERGY-MINIMIZED 
STRUCTURES OF THE REACTION PRODUCTS OF 2.1 WITH CYS (TOP) AND 
HCY (BOTTOM) 
 
Molecular models were built using the SYBYL™ software package version X-1.1 
(Tripos Inc.) and then submitted for geometry optimization and energy minimization via 
MOPAC2009.1 
 
The processed file which corresponds to Fig. 2.13 in the text is presented below in mol2 
file format.  To read the file, copy the text between "start of mol2 file" and "end of mol2 
file" and paste it in a text editor (e.g. MS notepad) and save the file with any name with 
the extension ".mol2"; this file can then be opened with almost any molecular viewer 
program (e.g. RASMOL, UCSF Chimera, Cambridgesoft Chem3D™, SYBYL™, etc.). 
 
Figure C1. Reaction product of 2.1-Cys 
 
START OF MOL2 FILE===(don't select this row)=== 
@<TRIPOS>MOLECULE 
monoaldehyde_cys 
   65    69     1     7     0 
SMALL 
DEL_RE 
 
 
@<TRIPOS>ATOM 
      1 C1         -4.271785    1.887905    2.729443 C.ar      1 <1>         0.096067  
      2 C2         -4.292719    0.497906    2.845009 C.ar      1 <1>        -0.045453  
      3 C3         -3.108904   -0.236785    2.754424 C.ar      1 <1>        -0.052621  
      4 C4         -1.903944    0.424791    2.496785 C.ar      1 <1>         0.011718  
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      5 C5         -1.874445    1.822419    2.457249 C.ar      1 <1>         0.101950  
      6 C6         -3.054840    2.567616    2.586960 C.ar      1 <1>         0.014974  
      7 C7         -0.621017   -0.336834    2.250014 C.2       1 <1>         0.002651  
      8 C8          0.509681    0.349957    2.040404 C.2       1 <1>         0.011821  
      9 C9          0.474955    1.830955    2.054087 C.2       1 <1>         0.103500  
     10 O10        -0.664246    2.493124    2.276109 O.3       1 <1>        -0.251252  
     11 C11         1.805274   -0.319266    1.778399 C.2       1 <1>        -0.053090  
     12 C12         2.919995    0.389104    1.567195 C.2       1 <1>        -0.049669  
     13 C13         2.873251    1.858476    1.589150 C.2       1 <1>         0.073607  
     14 C14         1.590976    2.534409    1.835137 C.2       1 <1>        -0.041535  
     15 O15         3.889731    2.508630    1.405529 O.2       1 <1>        -0.080412  
     16 O16        -5.483174    2.580279    2.757673 O.3       1 <1>        -1.116214  
     17 C17        -0.649226   -1.850073    2.216064 C.ar      1 <1>         0.002968  
     18 C18        -1.337378   -2.449080    1.155373 C.ar      1 <1>        -0.054366  
     19 C19        -1.383091   -3.839686    1.032471 C.ar      1 <1>        -0.053048  
     20 C20        -0.730988   -4.636954    1.975373 C.ar      1 <1>        -0.052964  
     21 C21        -0.054746   -4.039551    3.042615 C.ar      1 <1>        -0.053540  
     22 C22        -0.021564   -2.646573    3.185037 C.ar      1 <1>         0.011078  
     23 C23         0.689398   -2.050948    4.384143 C.2       1 <1>         0.134395  
     24 O24         0.621785   -0.814474    4.610588 O.co2     1 <1>        -0.572901  
     25 O25         1.342332   -2.814250    5.147988 O.co2     1 <1>        -0.572901  
     26 C26        -2.994432    4.108325    2.557814 C.3       1 <1>        -0.025966  
     27 C27        -3.391875    4.636279    1.153765 C.3       1 <1>        -0.049381  
     28 C28        -2.438928    4.110967    0.044950 C.3       1 <1>         0.012867  
     29 C29        -7.790990    6.099759    3.613355 C.2       1 <1>         0.129412  
     30 N30        -6.876538    3.978853    3.476148 N.4       1 <1>         0.252946  
     31 C31        -6.582531    5.316676    4.021755 C.3       1 <1>         0.063027  
     32 C32        -5.255146    5.898629    3.472078 C.3       1 <1>        -0.079593  
     33 S33        -3.897826    4.791071    4.003835 S.3       1 <1>        -0.049780  
     34 O34        -8.742245    5.369425    3.216952 O.co2     1 <1>        -0.573918  
     35 O35        -7.797279    7.353122    3.679456 O.co2     1 <1>        -0.573918  
     36 N36        -1.026538    4.515986    0.222001 N.3       1 <1>        -0.346211  
     37 C37        -0.366051    4.566765   -1.098815 C.3       1 <1>         0.055637  
     38 C38        -1.334551    5.326736   -2.033866 C.3       1 <1>        -0.078859  
     39 S39        -2.980850    4.715380   -1.584108 S.3       1 <1>        -0.047305  
     40 C40         0.966204    5.280203   -1.059102 C.2       1 <1>         0.128495  
     41 O41         1.111826    6.207612   -0.213889 O.co2     1 <1>        -0.574106  
     42 O42         1.868010    4.926382   -1.868709 O.co2     1 <1>        -0.574106  
     43 H45         1.881826   -1.405930    1.751828 H         1 <1>         0.052846  
     44 H46         3.871576   -0.108802    1.377619 H         1 <1>         0.053175  
     45 H47         1.551578    3.624396    1.835576 H         1 <1>         0.053959  
     46 H49        -1.838461   -1.828675    0.418666 H         1 <1>         0.052723  
     47 H50        -1.921112   -4.297601    0.208291 H         1 <1>         0.052850  
     48 H52         0.447362   -4.670163    3.769218 H         1 <1>         0.052802  
     49 H53        -6.294709    3.154412    3.870214 H         1 <1>         0.219410  
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     50 H54        -1.965756    4.444100    2.755795 H         1 <1>         0.048128  
     51 H55        -4.416205    4.305533    0.921283 H         1 <1>         0.040947  
     52 H56        -3.353959    5.736414    1.137969 H         1 <1>         0.040947  
     53 H57        -2.475313    3.011141   -0.003550 H         1 <1>         0.053215  
     54 H58        -6.400733    3.740655    2.531242 H         1 <1>         0.219410  
     55 H59        -7.921950    3.730717    3.368431 H         1 <1>         0.219410  
     56 H60        -6.566093    5.281696    5.122934 H         1 <1>         0.047633  
     57 H61        -5.337005    6.012469    2.384315 H         1 <1>         0.049676  
     58 H62        -5.081013    6.894131    3.908712 H         1 <1>         0.049676  
     59 H63        -0.939237    5.492461    0.683416 H         1 <1>         0.202795  
     60 H64        -0.216511    3.533001   -1.450642 H         1 <1>         0.046773  
     61 H65        -1.302997    6.404673   -1.812387 H         1 <1>         0.050147  
     62 H66        -1.105052    5.161218   -3.097247 H         1 <1>         0.050147  
     63 H68        -5.241092   -0.002448    3.004332 H         1 <1>         0.053581  
     64 H69        -3.139716   -1.312804    2.884242 H         1 <1>         0.052891  
     65 H76        -0.750130   -5.718174    1.880298 H         1 <1>         0.052858  
@<TRIPOS>BOND 
     1    1    2 ar    
     2    6    1 ar    
     3    1   16 1     
     4    2    3 ar    
     5    4    3 ar    
     6    5    4 ar    
     7    4    7 1     
     8    6    5 ar    
     9    5   10 1     
    10   26    6 1     
    11    7    8 2     
    12    7   17 1     
    13    9    8 1     
    14    8   11 1     
    15   10    9 1     
    16    9   14 2     
    17   11   12 2     
    18   11   43 1     
    19   13   12 1     
    20   12   44 1     
    21   14   13 1     
    22   13   15 2     
    23   14   45 1     
    24   17   18 ar    
    25   17   22 ar    
    26   18   19 ar    
    27   18   46 1     
    28   19   20 ar    
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    29   19   47 1     
    30   21   20 ar    
    31   22   21 ar    
    32   21   48 1     
    33   23   24 ar    
    34   23   25 ar    
    35   22   23 1     
    36   29   34 ar    
    37   27   26 1     
    38   26   33 1     
    39   26   50 1     
    40   28   27 1     
    41   27   51 1     
    42   27   52 1     
    43   36   28 1     
    44   39   28 1     
    45   28   53 1     
    46   29   35 ar    
    47   31   29 1     
    48   30   49 1     
    49   31   30 1     
    50   30   54 1     
    51   30   55 1     
    52   32   31 1     
    53   31   56 1     
    54   33   32 1     
    55   32   57 1     
    56   32   58 1     
    57   37   36 1     
    58   36   59 1     
    59   37   38 1     
    60   40   41 ar    
    61   37   60 1     
    62   38   39 1     
    63   38   61 1     
    64   38   62 1     
    65   40   42 ar    
    66   37   40 1     
    67    2   63 1     
    68    3   64 1     
    69   20   65 1     
@<TRIPOS>SUBSTRUCTURE 
     1 ****       30 TEMP              0 ****  ****    0 ROOT  
@<TRIPOS>ROTATABLE_BOND 
   37    40    10  1 1     0  0 
 69
   40    44    37  2 1     0  0 
   52    54    49  3 1     0  0 
   12    11    25  4 1     0  0 
   10    37     8  5 1     0  0 
@<TRIPOS>ANCHOR_ATOM 
26 
@<TRIPOS>NORMAL 
@<TRIPOS>DATA_FILE 
hbonds.dsp 0 7 
@<TRIPOS>FF_PBC 
FORCE_FIELD_SETUP_FEATURE Force Field Setup information 
v1.0  0 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 NONE 0 0 0 0 1 0 0 0 
0 0 0 0 0 
END OF MOL2 FILE====(don't select this row)=== 
 
 
Figure C2. Reaction product of 2.1-Hcy 
 
START OF MOL2 FILE===(don't select this row)=== 
@<TRIPOS>MOLECULE 
monoaldehyde_hcy 
   71    75     1     7     0 
SMALL 
GAST_HUCK 
 
 
@<TRIPOS>ATOM 
      1 C1         -6.534613    0.422702   -0.557650 C.ar      1 <1>         0.124991  
      2 C2         -6.570685   -0.966615   -0.687084 C.ar      1 <1>        -0.051937  
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      3 C3         -5.389475   -1.706431   -0.609638 C.ar      1 <1>        -0.084925  
      4 C4         -4.168483   -1.050315   -0.421090 C.ar      1 <1>        -0.022191  
      5 C5         -4.125109    0.346475   -0.392542 C.ar      1 <1>         0.117146  
      6 C6         -5.315492    1.084017   -0.366590 C.ar      1 <1>         0.032520  
      7 C7         -2.880802   -1.820198   -0.233226 C.2       1 <1>        -0.056295  
      8 C8         -1.727246   -1.139742   -0.198503 C.2       1 <1>        -0.033549  
      9 C9         -1.746075    0.338407   -0.330019 C.2       1 <1>         0.083583  
     10 O10        -2.900992    1.016373   -0.395512 O.3       1 <1>        -0.268794  
     11 C11        -0.418116   -1.810272   -0.017067 C.2       1 <1>        -0.099875  
     12 C12         0.726603   -1.119401   -0.067163 C.2       1 <1>        -0.081893  
     13 C13         0.701902    0.333962   -0.288849 C.2       1 <1>         0.015653  
     14 C14        -0.596284    1.021387   -0.377969 C.2       1 <1>        -0.048798  
     15 O15         1.745638    0.959990   -0.389876 O.2       1 <1>        -0.490113  
     16 O16        -7.723318    1.143142   -0.622416 O.3       1 <1>        -0.154283  
     17 C17        -2.945653   -3.324050   -0.062804 C.ar      1 <1>        -0.045568  
     18 C18        -2.372471   -4.157257   -1.028774 C.ar      1 <1>        -0.071718  
     19 C19        -2.465989   -5.546204   -0.904152 C.ar      1 <1>        -0.074928  
     20 C20        -3.142632   -6.103692    0.184380 C.ar      1 <1>        -0.073562  
     21 C21        -3.706565   -5.271394    1.155938 C.ar      1 <1>        -0.063999  
     22 C22        -3.592704   -3.881470    1.050167 C.ar      1 <1>        -0.005207  
     23 C23        -4.172120   -2.997726    2.135807 C.2       1 <1>         0.052084  
     24 C24        -5.737324    5.297926   -5.796789 C.2       1 <1>         0.051909  
     25 O25        -3.881314   -1.777082    2.206476 O.co2     1 <1>        -0.565249  
     26 C26        -5.295766    2.602954   -0.124000 C.3       1 <1>         0.036309  
     27 C27        -4.748255    3.389752   -1.346116 C.3       1 <1>        -0.009821  
     28 C28        -5.595687    3.161035   -2.627184 C.3       1 <1>         0.058136  
     29 C29        -5.665797    0.634918    5.265128 C.2       1 <1>         0.084434  
     30 N30        -5.542834   -0.972012    3.568600 N.4       1 <1>         0.232692  
     31 C31        -4.712298    0.024543    4.291267 C.3       1 <1>         0.029081  
     32 C32        -4.087549    1.126179    3.384049 C.3       1 <1>         0.011511  
     33 C33        -5.151741    1.984882    2.650098 C.3       1 <1>         0.002145  
     34 S34        -4.303720    2.975112    1.365720 S.3       1 <1>        -0.147693  
     35 O35        -4.513415    5.536035   -5.988577 O.co2     1 <1>        -0.567378  
     36 O36        -5.243494    1.344377    6.208579 O.co2     1 <1>        -0.564254  
     37 N37        -5.288815    4.196391   -3.635747 N.3       1 <1>        -0.289680  
     38 C38        -6.109339    4.164254   -4.869711 C.3       1 <1>         0.062359  
     39 C39        -5.931275    2.829803   -5.640961 C.3       1 <1>        -0.016543  
     40 C40        -6.341852    1.609093   -4.781135 C.3       1 <1>        -0.001891  
     41 S41        -5.253006    1.515403   -3.329831 S.3       1 <1>        -0.141588  
     42 O42        -6.665557    5.954671   -6.345124 O.co2     1 <1>        -0.567378  
     43 O43        -4.997437   -3.388496    3.009389 O.co2     1 <1>        -0.565249  
     44 O44        -6.868612    0.345931    5.019639 O.co2     1 <1>        -0.564254  
     45 H45        -7.519450   -1.468382   -0.845392 H         1 <1>         0.044353  
     46 H1         -6.665333    3.228499   -2.370902 H         1 <1>         0.057808  
     47 H47        -0.355547   -2.882651    0.164829 H         1 <1>         0.045622  
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     48 H48         1.688765   -1.617463    0.057916 H         1 <1>         0.022334  
     49 H49        -0.613745    2.106528   -0.481748 H         1 <1>         0.008392  
     50 H2         -7.167771    4.296723   -4.593987 H         1 <1>         0.062970  
     51 H52        -2.015280   -6.190114   -1.652718 H         1 <1>         0.058985  
     52 H3         -6.552237    2.855927   -6.551855 H         1 <1>         0.030606  
     53 H4         -6.227368    0.677398   -5.357001 H         1 <1>         0.037832  
     54 H55        -6.305431    2.976373    0.108825 H         1 <1>         0.052431  
     55 H56        -4.782871    4.464150   -1.102549 H         1 <1>         0.031564  
     56 H57        -3.698804    3.125011   -1.545949 H         1 <1>         0.031564  
     57 H59        -5.279569   -0.989000    2.523941 H         1 <1>         0.200999  
     58 H60        -5.418349   -1.994381    3.904979 H         1 <1>         0.200999  
     59 H61        -3.905875   -0.474747    4.853929 H         1 <1>         0.102447  
     60 H62        -3.462304    1.794917    3.998749 H         1 <1>         0.034655  
     61 H63        -3.428588    0.648045    2.641002 H         1 <1>         0.034655  
     62 H64        -5.921034    1.350315    2.189649 H         1 <1>         0.038070  
     63 H65        -5.652280    2.666544    3.355748 H         1 <1>         0.038070  
     64 H66        -4.237207    4.189824   -3.895821 H         1 <1>         0.125177  
     65 H69        -4.877591    2.724878   -5.946678 H         1 <1>         0.030606  
     66 H71        -7.388450    1.694501   -4.449729 H         1 <1>         0.037832  
     67 H72        -6.605188   -0.765705    3.628427 H         1 <1>         0.200999  
     68 H75        -5.432367   -2.786555   -0.697090 H         1 <1>         0.042588  
     69 H80        -1.857935   -3.722011   -1.879540 H         1 <1>         0.051829  
     70 H82        -3.229505   -7.181765    0.276395 H         1 <1>         0.049737  
     71 H83        -4.234002   -5.703230    2.000204 H         1 <1>         0.060932  
@<TRIPOS>BOND 
     1    1    2 ar    
     2    6    1 ar    
     3    1   16 1     
     4    2    3 ar    
     5    2   45 1     
     6    4    3 ar    
     7   28   46 1     
     8    5    4 ar    
     9    4    7 1     
    10    6    5 ar    
    11    5   10 1     
    12   26    6 1     
    13    7    8 2     
    14    7   17 1     
    15    9    8 1     
    16    8   11 1     
    17   10    9 1     
    18    9   14 2     
    19   11   12 2     
    20   11   47 1     
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    21   13   12 1     
    22   12   48 1     
    23   14   13 1     
    24   13   15 2     
    25   14   49 1     
    26   17   18 ar    
    27   17   22 ar    
    28   18   19 ar    
    29   38   50 1     
    30   19   20 ar    
    31   19   51 1     
    32   21   20 ar    
    33   39   52 1     
    34   22   21 ar    
    35   40   53 1     
    36   23   25 ar    
    37   24   35 ar    
    38   23   43 ar    
    39   24   42 ar    
    40   27   26 1     
    41   26   34 1     
    42   26   54 1     
    43   28   27 1     
    44   27   55 1     
    45   27   56 1     
    46   37   28 1     
    47   28   41 1     
    48   29   36 ar    
    49   38   24 1     
    50   29   44 ar    
    51   31   30 1     
    52   30   57 1     
    53   30   58 1     
    54   32   31 1     
    55   31   59 1     
    56   33   32 1     
    57   32   60 1     
    58   32   61 1     
    59   34   33 1     
    60   33   62 1     
    61   33   63 1     
    62   22   23 1     
    63   38   37 1     
    64   37   64 1     
    65   39   38 1     
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    66   31   29 1     
    67   39   40 1     
    68   39   65 1     
    69   40   41 1     
    70   40   66 1     
    71   30   67 1     
    72    3   68 1     
    73   18   69 1     
    74   20   70 1     
    75   21   71 1     
@<TRIPOS>SUBSTRUCTURE 
     1 ****       29 TEMP              0 ****  ****    0 ROOT  
@<TRIPOS>ROTATABLE_BOND 
   14    13    27  1 1     0  0 
   12    40    10  2 1     0  0 
   43    47    40  3 1     0  0 
   40    43    12  4 1     0  0 
   56    59    54  5 1     0  0 
@<TRIPOS>ANCHOR_ATOM 
7 
@<TRIPOS>NORMAL 
@<TRIPOS>DATA_FILE 
hbonds.dsp 0 7 
@<TRIPOS>FF_PBC 
FORCE_FIELD_SETUP_FEATURE Force Field Setup information 
v1.0  0 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 NONE 0 0 0 0 1 0 0 0 
0 0 0 0 0 
END OF MOL2 FILE====(don't select this row)=== 
 
Molecular graphics images were produced using the UCSF Chimera2 package from the 
Resource for Biocomputing, Visualization, and Informatics at the University of 
California, San Francisco (supported by NIH P41 RR001081). 
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APPENDIX D. CHARACTERIZATION DATA FOR COMPOUND 3.1 
 
 
 
 
Figure D1. 1H NMR of 3.1 in CD3OD (400 MHz) 
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Figure D2. 13C NMR of 3.1 (in CD3OD 101 MHz) 
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Figure D3. MALDI-TOF of 3.1 
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Figure D4.  HPLC chromatograms from the preparation of 3.1 at various conditions. 
Peak 1 corresponds to rhodamine 110 and peak 3 to compound 3.1. A) using 2 
equivalents of 2-formylphenylboronic acid and irradiated to keep the reaction at 90 ºC for 
8 min.  B) same as above but increasing the temperature to 110 ºC and time to 10 min.  
C) using 5 equivalents of 2-formylphenylboronic acid and keeping the temperature at 130 
ºC for 20 min. HPLC conditions:  sample size: 20 µL; flow rate: 1 mL/min; mobile 
phase: gradient 50% MeOH/H2O to 100% MeOH in 10 min); detection wavelength: 520 
nm. 
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APPENDIX E. COMPUTATIONAL PROCEDURES OF ENERGY-MINIMIZED 
MODEL OF THE BORONATE ESTER FORMED AFTER CONDENSATION OF 
ONE EQUIVALENT OF AN AICAR TO 3.1. 
 
 
 
Molecular models were built using the SYBYL™ software package version X-1.1 
(Tripos Inc.) and then submitted for geometry optimization and energy minimization via 
MOPAC20091 with the following command keywords: PM6 CHARGE=-2 EF GEO-OK 
GNORM=0.100 MMOK SHIFT=80. 
 
The processed file which corresponds to Fig. 3.2 in the text is presented below in mol2 
file format.  To read the file, copy the text between "start of mol2 file" and "end of mol2 
file" and paste it in a text editor (e.g. MS notepad) and save the file with any name with 
the extension ".mol2"; this file can then be opened with almost any molecular viewer 
program (e.g. RASMOL, UCSF Chimera, Cambridgesoft Chem3D™, SYBYL™, etc.). 
 
START OF MOL2 FILE===(don't select this row)=== 
@<TRIPOS>MOLECULE 
AICAr-1_monoboronate 
101 109 1 0 0 
SMALL 
USER_CHARGES 
 
 
@<TRIPOS>ATOM 
      1 N           1.5071   -0.3078    4.0600 N.am      1     ****    0.0000 
      2 H           0.7189   -0.5053    4.6623 H         1     ****    0.0000 
      3 H           2.3333   -0.0232    4.5717 H         1     ****    0.0000 
      4 C           1.0662   -4.8262    0.4011 C.2       1     ****    0.0000 
      5 C          -0.2354   -4.6591   -0.1163 C.2       1     ****    0.0000 
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      6 C          -0.4057   -3.7731   -1.1764 C.2       1     ****    0.0000 
      7 C           0.6529   -3.0825   -1.8135 C.2       1     ****    0.0000 
      8 C           1.9629   -3.3105   -1.2934 C.2       1     ****    0.0000 
      9 C           2.1692   -4.1477   -0.2259 C.2       1     ****    0.0000 
     10 C           0.2384   -6.2043    2.3200 C.3       1     ****    0.0000 
     11 C           0.7133   -6.3840    3.7399 C.ar      1     ****    0.0000 
     12 C           0.9297   -5.2744    4.5651 C.ar      1     ****    0.0000 
     13 C           1.3413   -5.4381    5.8870 C.ar      1     ****    0.0000 
     14 C           1.5442   -6.7262    6.3949 C.ar      1     ****    0.0000 
     15 C           1.3377   -7.8412    5.5760 C.ar      1     ****    0.0000 
     16 C           0.9251   -7.6733    4.2512 C.ar      1     ****    0.0000 
     17 N           1.3396   -5.6831    1.4587 N.pl3     1     ****    1.0000 
     18 B           0.7329   -3.8259    4.0038 B         1     ****    0.0000 
     19 O          -0.4326   -3.1644    4.2270 O.3       1     ****    0.0000 
     20 O           1.7574   -3.2744    3.2820 O.3       1     ****    0.0000 
     21 O          -1.7252   -3.6081   -1.5686 O.3       1     ****    0.0000 
     22 C          -2.0254   -2.5689   -2.4473 C.ar      1     ****    0.0000 
     23 C          -0.9729   -1.8349   -3.1000 C.ar      1     ****    0.0000 
     24 C           0.3585   -2.1295   -2.8414 C.2       1     ****    0.0000 
     25 C          -3.3643   -2.3359   -2.6164 C.ar      1     ****    0.0000 
     26 C          -3.7612   -1.1988   -3.3994 C.ar      1     ****    0.0000 
     27 C          -2.7266   -0.4142   -4.0530 C.ar      1     ****    0.0000 
     28 C          -1.4085   -0.7133   -3.9123 C.ar      1     ****    0.0000 
     29 N          -5.0554   -0.8580   -3.6066 N.pl3     1     ****    0.0000 
     30 C          -6.1730   -1.4786   -2.8335 C.3       1     ****    0.0000 
     31 C          -7.3361   -0.5252   -2.7250 C.ar      1     ****    0.0000 
     32 C          -8.5923   -0.8997   -3.2282 C.ar      1     ****    0.0000 
     33 C          -9.6868   -0.0459   -3.0788 C.ar      1     ****    0.0000 
     34 C          -9.5302    1.1863   -2.4300 C.ar      1     ****    0.0000 
     35 C          -8.2792    1.5632   -1.9387 C.ar      1     ****    0.0000 
     36 C          -7.1789    0.7125   -2.0856 C.ar      1     ****    0.0000 
     37 C           1.4684   -1.5381   -3.6250 C.ar      1     ****    0.0000 
     38 C           2.0618   -2.3331   -4.6243 C.ar      1     ****    0.0000 
     39 C           3.1056   -1.8199   -5.3919 C.ar      1     ****    0.0000 
     40 C           3.5748   -0.5194   -5.1585 C.ar      1     ****    0.0000 
     41 C           2.9939    0.2625   -4.1609 C.ar      1     ****    0.0000 
     42 C           1.9322   -0.2392   -3.3956 C.ar      1     ****    0.0000 
     43 C           1.3186    0.6600   -2.3080 C.2       1     ****    0.0000 
     44 O           0.0767    0.8090   -2.3486 O.co2     1     ****   -1.0000 
     45 O           2.1030    1.1522   -1.4837 O.co2     1     ****    0.0000 
     46 B          -5.7555    1.2022   -1.5675 B         1     ****   -1.0000 
     47 O          -4.9794    0.0960   -0.8773 O.3       1     ****    0.0000 
     48 O          -5.8321    2.2922   -0.5450 O.3       1     ****    0.0000 
     49 O          -4.9750    1.6431   -2.7212 O.3       1     ****    0.0000 
     50 H          -0.5969   -2.2830    3.8337 H         1     ****    0.0000 
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     51 N          -1.8427    0.4574    0.8811 N.ar      1     ****    0.0000 
     52 C          -3.0164    3.6762    1.3770 C.3       1     ****    0.0000 
     53 C          -4.2702    0.6449    0.1849 C.3       1     ****    0.0000 
     54 C          -4.8215    2.0984    0.3992 C.3       1     ****    0.0000 
     55 C          -3.6205    3.0377    0.1211 C.3       1     ****    0.0000 
     56 O          -2.5823    2.2273   -0.4953 O.3       1     ****    0.0000 
     57 C          -2.7739    0.8374   -0.2204 C.3       1     ****    0.0000 
     58 O          -3.7581    4.8424    1.7635 O.3       1     ****    0.0000 
     59 C          -2.1197   -0.4250    1.9773 C.ar      1     ****    0.0000 
     60 N          -1.0637   -0.5628    2.7749 N.ar      1     ****    0.0000 
     61 C          -0.0362    0.2434    2.2382 C.ar      1     ****    0.0000 
     62 C          -0.4961    0.8803    1.0421 C.ar      1     ****    0.0000 
     63 C           1.2625    0.4125    2.8468 C.2       1     ****    0.0000 
     64 O           2.1849    1.0730    2.3890 O.2       1     ****    0.0000 
     65 N           0.1294    1.8007    0.2542 N.3       1     ****    0.0000 
     66 H          -1.1005   -5.1575    0.3106 H         1     ****    0.0000 
     67 H           2.8023   -2.7755   -1.7532 H         1     ****    0.0000 
     68 H           3.1713   -4.2802    0.1787 H         1     ****    0.0000 
     69 H          -0.6513   -5.5243    2.3070 H         1     ****    0.0000 
     70 H          -0.1033   -7.1708    1.8797 H         1     ****    0.0000 
     71 H           1.5016   -4.5688    6.5239 H         1     ****    0.0000 
     72 H           1.8628   -6.8597    7.4264 H         1     ****    0.0000 
     73 H           1.4981   -8.8421    5.9700 H         1     ****    0.0000 
     74 H           0.7688   -8.5445    3.6182 H         1     ****    0.0000 
     75 H           1.7073   -2.3481    3.0040 H         1     ****    0.0000 
     76 H          -4.1052   -2.9354   -2.0943 H         1     ****    0.0000 
     77 H          -3.0346    0.4709   -4.6138 H         1     ****    0.0000 
     78 H          -0.6285   -0.0862   -4.3648 H         1     ****    0.0000 
     79 H          -5.2464    0.1377   -3.8985 H         1     ****    0.0000 
     80 H          -5.8319   -1.7242   -1.7892 H         1     ****    0.0000 
     81 H          -6.4563   -2.4293   -3.3341 H         1     ****    0.0000 
     82 H          -8.7168   -1.8533   -3.7328 H         1     ****    0.0000 
     83 H         -10.6581   -0.3356   -3.4655 H         1     ****    0.0000 
     84 H         -10.3836    1.8483   -2.3126 H         1     ****    0.0000 
     85 H          -8.1394    2.5203   -1.4326 H         1     ****    0.0000 
     86 H           1.7007   -3.3445   -4.7984 H         1     ****    0.0000 
     87 H           3.5588   -2.4290   -6.1699 H         1     ****    0.0000 
     88 H           4.3948   -0.1236   -5.7536 H         1     ****    0.0000 
     89 H           3.3628    1.2693   -3.9504 H         1     ****    0.0000 
     90 H          -4.1496    2.0436   -2.4744 H         1     ****    0.0000 
     91 H          -1.9984    4.0682    1.1726 H         1     ****    0.0000 
     92 H          -2.9658    2.9816    2.2326 H         1     ****    0.0000 
     93 H          -4.4170   -0.0225    1.0543 H         1     ****    0.0000 
     94 H          -5.2763    2.2593    1.3938 H         1     ****    0.0000 
     95 H          -3.8617    3.7962   -0.6567 H         1     ****    0.0000 
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     96 H          -2.4686    0.3275   -1.1699 H         1     ****    0.0000 
     97 H          -4.7158    4.6465    1.7839 H         1     ****    0.0000 
     98 H          -3.0796   -0.9071    2.0882 H         1     ****    0.0000 
     99 H           1.1708    1.7766    0.2468 H         1     ****    0.0000 
    100 H          -0.2472    1.9518   -0.7034 H         1     ****    0.0000 
    101 H           2.2215   -5.5267    1.9622 H         1     ****    0.0000 
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Molecular graphics images were produced using the UCSF Chimera2 package from the 
Resource for Biocomputing, Visualization, and Informatics at the University of 
California, San Francisco (supported by NIH P41 RR001081). 
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